tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders StocksTop Gainers/ Losers/ Active StocksMost Visited WebsitesDividend StocksChatGPT StocksLargest Companies by Market Cap
ETFs
Top ETFs by Upside
New
Top ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
New
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Research Tools
Stock ScreenerETF Screener
Popular
Trending StocksDaily Analyst RatingsCompare StocksCompare ETFsPenny Stock ScreenerTechnical Analysis ScreenerDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Personal Finance CenterMortgagesLoansInvesting & RetirementSpending & Savings
Calculators
401k Retirement CalculatorMortgage Calculator
Popular
Compound Interest CalculatorDollar Cost Averaging
New
Student Loan CalculatorAuto Loan Calculator
Education
How To Use TipRanksTipRanks LabsWebinar CenterGlossaryFAQs
About Us
About TipRanksTipRanks CommunityContact UsCareersReviewsMobile APP
Working with TipRanks
Enterprise SolutionsTop Online BrokersBecome an Affiliate
Follow Us
NewsSmart PortfolioExpert CenterTipRanksAI
TOOLS
My Portfolio
My Watchlist
Earnings Calendar
Stock Screener
Penny Stocks
Top Stocks
Daily Analyst Ratings
STOCKS
BABA
AAPL
SPY
AMZN
QQQ
TSLA
NVDA
ADVANCED RESEARCH
TipRanks Premium
Invest Like a Pro with Unique Data & Simplifed ToolsTry Now
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders Stocks
Top Gainers/ Losers/ Active Stocks
Most Visited Websites
Dividend Stocks
ChatGPT Stocks
Largest Companies by Market Cap
ETFs
ETF Center
Top ETFs by Upside
New
Top ETFs by Smart Score
Top Gainers/ Losers/ Active ETFs
Options
Options Market Overview
Unusual Options Activity
Popular
Most Active Options
Options Volume Leaders
Commodities
Gold
New
Crypto
Crypto Center
Bitcoin
Popular
Ethereum
Currency
Currency Center
EUR/USD
Research Tools
Stock Screener
ETF Screener
Popular
Trending Stocks
Daily Analyst Ratings
Compare Stocks
Compare ETFs
Penny Stock Screener
Technical Analysis Screener
Daily Insider Trading Tracker
Calendars
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
Market Holidays
Economic Indicators
Economic Indicators Center
Inflation Rate
Unemployment Rate
Federal Funds Rate
Calculators
Dividend Calculator
Dividend Yield Calculator
Options Profit Calculator
Dollar Cost Averaging
New
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
News
Portfolio
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Calculators
Compound Interest Calculator
New
Mortgage Calculator
Popular
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Enterprise Solutions
Plans & Pricing
Education
How To Use TipRanks
TipRanks Labs
Webinar Center
Glossary
FAQs
About Us
About TipRanks
TipRanks Community
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
Follow Us

AKRO Stock Latest News

Akero Therapeutics Reports First Quarter 2024 Financial Results and Provides Business Update
Press ReleasesAkero Therapeutics Reports First Quarter 2024 Financial Results and Provides Business Update
3h ago
AKRO
Akero Therapeutics appoints Gangloff as Chief Technology Officer
PremiumThe Fly
Akero Therapeutics appoints Gangloff as Chief Technology Officer
10d ago
AKRO
Akero Therapeutics reinstated with a Neutral at BofA
PremiumThe Fly
Akero Therapeutics reinstated with a Neutral at BofA
18d ago
AKRO
JPMorgan SMid cap biotech analyst to hold analyst/industry conference call
PremiumThe Fly
JPMorgan SMid cap biotech analyst to hold analyst/industry conference call
2M ago
AKRO
Akero Therapeutics Announces Closing of Public Offering of Common Stock and Full Exercise of Underwriters’ Option to Purchase Additional Shares
PremiumPress Releases
Akero Therapeutics Announces Closing of Public Offering of Common Stock and Full Exercise of Underwriters’ Option to Purchase Additional Shares
2M ago
AKRO
Akero Therapeutics Announces Publication of Phase 2b SYMMETRY Cohort D Study in Clinical Gastroenterology and Hepatology
PremiumPress ReleasesAkero Therapeutics Announces Publication of Phase 2b SYMMETRY Cohort D Study in Clinical Gastroenterology and Hepatology
2M ago
AKRO
89bio price target raised to $37 from $29 at Evercore ISI
PremiumThe Fly
89bio price target raised to $37 from $29 at Evercore ISI
2M ago
AKRO
ETNB
Biotech Alert: Searches spiking for these stocks today
PremiumThe Fly
Biotech Alert: Searches spiking for these stocks today
2M ago
AKRO
BBIO
Akero Therapeutics Announces Pricing of Public Offering of Common Stock
PremiumPress Releases
Akero Therapeutics Announces Pricing of Public Offering of Common Stock
2M ago
AKRO
Akero Therapeutics 11M share Secondary priced at $29.00
PremiumThe Fly
Akero Therapeutics 11M share Secondary priced at $29.00
2M ago
AKRO
Akero Therapeutics price target raised to $50 from $43 at H.C. Wainwright
PremiumThe Fly
Akero Therapeutics price target raised to $50 from $43 at H.C. Wainwright
2M ago
AKRO
Akero Therapeutics announces $300M common stock offering
PremiumThe Fly
Akero Therapeutics announces $300M common stock offering
2M ago
AKRO
Akero Therapeutics Announces Proposed Public Offering of Common Stock
PremiumPress ReleasesAkero Therapeutics Announces Proposed Public Offering of Common Stock
2M ago
AKRO
Akero Therapeutics price target raised to $50 from $35 at Jefferies
PremiumThe Fly
Akero Therapeutics price target raised to $50 from $35 at Jefferies
2M ago
AKRO
Akero Therapeutics price target raised to $50 from $36 at Evercore ISI
PremiumThe Fly
Akero Therapeutics price target raised to $50 from $36 at Evercore ISI
2M ago
AKRO
Akero upside capped on bone mineral density questions, says Cantor
PremiumThe Fly
Akero upside capped on bone mineral density questions, says Cantor
2M ago
AKRO
Akero 96-week update ‘posiitve’ for 89Bio, says Raymond James
PremiumThe Fly
Akero 96-week update ‘posiitve’ for 89Bio, says Raymond James
2M ago
AKRO
ETNB
Akero Therapeutics’ EFX Shows Promise in Phase 2b MASH Study
PremiumCompany Announcements
Akero Therapeutics’ EFX Shows Promise in Phase 2b MASH Study
2M ago
8K
AKRO
Akero Therapeutics to host conference call
PremiumThe Fly
Akero Therapeutics to host conference call
2M ago
AKRO
Akero Therapeutics Reports Statistically Significant Histological Improvements at Week 96 in Phase 2b HARMONY Study
PremiumPress ReleasesAkero Therapeutics Reports Statistically Significant Histological Improvements at Week 96 in Phase 2b HARMONY Study
2M ago
AKRO
Akero Therapeutics reports results from Phase 2B HARMONY study
PremiumThe Fly
Akero Therapeutics reports results from Phase 2B HARMONY study
2M ago
AKRO
Akero Therapeutics to host conference call
PremiumThe Fly
Akero Therapeutics to host conference call
2M ago
AKRO

Trending

Name
Price
Price Change
SPX
S&P 500
DJIA
Dow Jones
NDX
Nasdaq 100
More Trending Stocks >